Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccine-Breakthrough Infection Phenotype Includes Significant Symptoms, Live Virus Shedding, and Viral Genetic Diversity.
Pollett SD, Richard SA, Fries AC, Simons MP, Mende K, Lalani T, Lee T, Chi S, Mody R, Madar C, Ganesan A, Larson DT, Colombo CJ, Colombo R, Samuels EC, Broder CC, Laing ED, Smith DR, Tribble D, Agan BK, Burgess TH. Pollett SD, et al. Among authors: fries ac. Clin Infect Dis. 2022 Mar 9;74(5):897-900. doi: 10.1093/cid/ciab543. Clin Infect Dis. 2022. PMID: 34117878 Free PMC article.
Clinical, Immunological, and Virological SARS-CoV-2 Phenotypes in Obese and Nonobese Military Health System Beneficiaries.
Epsi NJ, Richard SA, Laing ED, Fries AC, Millar E, Simons MP, English C, Colombo CJ, Colombo RE, Lindholm DA, Ganesan A, Maves RC, Huprikar N, Larson D, Mende K, Chi SW, Madar C, Lalani T, Broder CC, Tribble D, Agan BK, Burgess TH, Pollett SD; EPICC COVID-19 Cohort Study Group. Epsi NJ, et al. Among authors: fries ac. J Infect Dis. 2021 Nov 16;224(9):1462-1472. doi: 10.1093/infdis/jiab396. J Infect Dis. 2021. PMID: 34331541 Free PMC article.
COVID-19 Outcomes Among US Military Health System Beneficiaries Include Complications Across Multiple Organ Systems and Substantial Functional Impairment.
Richard SA, Pollett SD, Lanteri CA, Millar EV, Fries AC, Maves RC, Utz GC, Lalani T, Smith A, Mody RM, Ganesan A, Colombo RE, Colombo CJ, Lindholm DA, Madar C, Chi S, Huprikar N, Larson DT, Bazan SE, English C, Parmelee E, Mende K, Laing ED, Broder CC, Blair PW, Chenoweth JG, Simons MP, Tribble DR, Agan BK, Burgess TH; EPICC COVID-19 Cohort Study Group. Richard SA, et al. Among authors: fries ac. Open Forum Infect Dis. 2021 Nov 10;8(12):ofab556. doi: 10.1093/ofid/ofab556. eCollection 2021 Dec. Open Forum Infect Dis. 2021. PMID: 34909439 Free PMC article.
SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster.
Lusvarghi S, Pollett SD, Neerukonda SN, Wang W, Wang R, Vassell R, Epsi NJ, Fries AC, Agan BK, Lindholm DA, Colombo CJ, Mody R, Ewers EC, Lalani T, Ganesan A, Goguet E, Hollis-Perry M, Coggins SA, Simons MP, Katzelnick LC, Wang G, Tribble DR, Bentley L, Eakin AE, Broder CC, Erlandson KJ, Laing ED, Burgess TH, Mitre E, Weiss CD. Lusvarghi S, et al. Among authors: fries ac. bioRxiv [Preprint]. 2021 Dec 28:2021.12.22.473880. doi: 10.1101/2021.12.22.473880. bioRxiv. 2021. Update in: Sci Transl Med. 2022 May 18;14(645):eabn8543. doi: 10.1126/scitranslmed.abn8543 PMID: 34981057 Free PMC article. Updated. Preprint.
Anatomical Site, Viral Ribonucleic Acid Abundance, and Time of Sampling Correlate With Molecular Detection of Severe Acute Respiratory Syndrome Coronavirus 2 During Infection.
Lantry FJ, Epsi NJ, Pollett SD, Simons MP, Lindholm DA, Colombo RE, Fries AC, Maves RC, Ganesan A, Utz GC, Lalani T, Smith AG, Mody RM, Colombo CJ, Chi SW, Madar C, Huprikar N, Larson DT, Bazan S, Broder CC, Laing ED, English C, Lanteri C, Mende K, Tribble DR, Agan BK, Burgess TH, Richard SA; EPICC COVID-19 Cohort Study Group. Lantry FJ, et al. Among authors: fries ac. Open Forum Infect Dis. 2021 Dec 8;9(3):ofab623. doi: 10.1093/ofid/ofab623. eCollection 2022 Mar. Open Forum Infect Dis. 2021. PMID: 35141345 Free PMC article.
SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum but evades most convalescent serum and therapeutic antibodies.
Lusvarghi S, Pollett SD, Neerukonda SN, Wang W, Wang R, Vassell R, Epsi NJ, Fries AC, Agan BK, Lindholm DA, Colombo CJ, Mody R, Ewers EC, Lalani T, Ganesan A, Goguet E, Hollis-Perry M, Coggins SA, Simons MP, Katzelnick LC, Wang G, Tribble DR, Bentley L, Eakin AE, Broder CC, Erlandson KJ, Laing ED, Burgess TH, Mitre E, Weiss CD. Lusvarghi S, et al. Among authors: fries ac. Sci Transl Med. 2022 May 18;14(645):eabn8543. doi: 10.1126/scitranslmed.abn8543. Epub 2022 May 18. Sci Transl Med. 2022. PMID: 35380448 Free PMC article.
Understanding "Hybrid Immunity": Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Vaccines.
Epsi NJ, Richard SA, Lindholm DA, Mende K, Ganesan A, Huprikar N, Lalani T, Fries AC, Maves RC, Colombo RE, Larson DT, Smith A, Chi SW, Maldonado CJ, Ewers EC, Jones MU, Berjohn CM, Libraty DH, Edwards MS, English C, Rozman JS, Mody RM, Colombo CJ, Samuels EC, Nwachukwu P, Tso MS, Scher AI, Byrne C, Rusiecki J, Simons MP, Tribble D, Broder CC, Agan BK, Burgess TH, Laing ED, Pollett SD; Epidemiology, Immunology, and Clinical Characteristics of Emerging Infectious Diseases with Pandemic Potential COVID-19 Cohort Study Group. Epsi NJ, et al. Among authors: fries ac. Clin Infect Dis. 2023 Feb 8;76(3):e439-e449. doi: 10.1093/cid/ciac392. Clin Infect Dis. 2023. PMID: 35608504 Free PMC article.
COVID-19 Patient-Reported Symptoms Using FLU-PRO Plus in a Cohort Study: Associations With Infecting Genotype, Vaccine History, and Return to Health.
Richard SA, Epsi NJ, Lindholm DA, Malloy AMW, Maves RC, Berjohn CM, Lalani T, Smith AG, Mody RM, Ganesan A, Huprikar N, Colombo RE, Colombo CJ, Madar C, Jones MU, Larson DT, Ewers EC, Bazan S, Fries AC, Maldonado CJ, Simons MP, Rozman JS, Andronescu L, Mende K, Tribble DR, Agan BK, Burgess TH, Pollett SD, Powers JH 3rd; EPICC COVID-19 Cohort Study Group. Richard SA, et al. Among authors: fries ac. Open Forum Infect Dis. 2022 Jun 7;9(7):ofac275. doi: 10.1093/ofid/ofac275. eCollection 2022 Jul. Open Forum Infect Dis. 2022. PMID: 35873301 Free PMC article.
Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination history.
Wang W, Lusvarghi S, Subramanian R, Epsi NJ, Wang R, Goguet E, Fries AC, Echegaray F, Vassell R, Coggins SA, Richard SA, Lindholm DA, Mende K, Ewers EC, Larson DT, Colombo RE, Colombo CJ, Joseph JO, Rozman JS, Smith A, Lalani T, Berjohn CM, Maves RC, Jones MU, Mody R, Huprikar N, Livezey J, Saunders D, Hollis-Perry M, Wang G, Ganesan A, Simons MP, Broder CC, Tribble DR, Laing ED, Agan BK, Burgess TH, Mitre E, Pollett SD, Katzelnick LC, Weiss CD. Wang W, et al. Among authors: fries ac. Cell Host Microbe. 2022 Dec 14;30(12):1745-1758.e7. doi: 10.1016/j.chom.2022.10.012. Epub 2022 Oct 21. Cell Host Microbe. 2022. PMID: 36356586 Free PMC article.
Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection.
Richard SA, Pollett SD, Fries AC, Berjohn CM, Maves RC, Lalani T, Smith AG, Mody RM, Ganesan A, Colombo RE, Lindholm DA, Morris MJ, Huprikar N, Colombo CJ, Madar C, Jones M, Larson DT, Bazan SE, Mende K, Saunders D, Livezey J, Lanteri CA, Scher AI, Byrne C, Rusiecki J, Ewers E, Epsi NJ, Rozman JS, English C, Simons MP, Tribble DR, Agan BK, Burgess TH; Epidemiology, Immunology, and Clinical Characteristics of Emerging Infectious Diseases With Pandemic Potential (EPICC) COVID-19 Cohort Study Group. Richard SA, et al. Among authors: fries ac. JAMA Netw Open. 2023 Jan 3;6(1):e2251360. doi: 10.1001/jamanetworkopen.2022.51360. JAMA Netw Open. 2023. PMID: 36652247 Free PMC article.
39 results